R

ise and shine, everyone, another busy day is on the way. And we are no exception as we hunt for interesting and insightful developments, a never-ending task. To cope, we are reaching for yet another cup of stimulation and, as always, invite you to join us. And why not? No prescription is required. Meanwhile, here are some tidbits to motor you along. Hope you have a smashing day and do keep in touch. We are eager to hear secrets, you know …

Several major drug makers have suppressed a campaign led by the Interfaith Center on Corporate Responsibility that was aimed at forcing the companies to disclose and justify price hikes, the Wall Street Journal reports. Ten of 11 companies approached will omit shareholder proposals on the grounds these would interfere with “ordinary business,” according to company documents filed with the Securities and Exchange Commission.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy